Companies formed

Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.

Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.


Platform technology based on NG capture-c technique computational pipelines and experimental know-how.

Incorporated in July 2019

Origin: Oxford University, MRC Weatherall Institute of Molecular Medicine

Contact: Matthew Carpenter

"CRIS" software that enables submission, de-identification and sharing of mental health patient records using a federated data and information governance model.

Incorporated in May 2019

Origin: Oxford University, Psychiatry


OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory

Incorporated in December 2018

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

Contact: Adam Workman

OxStem Beta will generate novel therapies to stimulate formation of new beta cells in the pancreas
(neogenesis) by targeting pathways that are normally only active during development or following
pancreatic injury.

Incorporated in December 2018

Origin: Oxford University, Pathology

A not for profit company providing a solution and accreditation to businesses that work to bring their workforce out of multidimensional poverty

Incorporated in November 2018

Origin: Oxford University, International Development

Contact: Mark Mann

Cocotec builds software tools, which harness the power of automated formal verification. Its product, the Coco Platform, comes with a powerful software development environment that enables developers to build their software, automatically verify whether it is correct, and then generate high quality reliable code.

Incorporated in November 2018

Origin: Oxford University, Department of Computer Science

Developing a brain implant to treat a variety of diseases.

Incorporated in October 2018

Origin: Oxford University, Nuffield Department of Surgical Sciences

A novel cancer cell therapy company, delivering tumour-targeted expression of anti-cancer biologics.

Incorporated in October 2018

Origin: Oxford University, Clinical Pharmacology

Development and application of bacterial biosensors for detection and quantification of environmental contamination, including organics and metals, on-site and in real-time.

Incorporated in August 2018

Origin: Oxford University, Engineering

Contact: Andy Robertson

Software development for a novel biomarker to detect coronary heart disease.

Incorporated in July 2018

Origin: Oxford University, Radcliffe department of medicine

Contact: James Groves

Ready to get in touch?

Contact Us
© Oxford University Innovation